The bears have been out in full force for Novavax (NVAX) this year and there has been little love in the current climate for this once high-flyer. Late for the Covid-19 vaccine party on account of manufacturing issues and beset by disappointing sales, sentiment has soured badly. All told, year-to-date, the shares have retreated by a massive 86% with the stock’s Covid-era triumphs well and truly gone. That said, not all are predicting doom and gloom for Novavax. Ahead of the Q3 print today, B.
https://www.tipranks.com/news/article/novavax-earnings-are-coming-heres-what-matters?utm_source=advfn.com&utm_medium=referral
Novavax (NASDAQ:NVAX)
Historical Stock Chart
Von Jan 2023 bis Feb 2023 Click Here for more Novavax Charts.
Novavax (NASDAQ:NVAX)
Historical Stock Chart
Von Feb 2022 bis Feb 2023 Click Here for more Novavax Charts.